Matti Lehtinen

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF INFECTIOUS DISEASES. 2022;226(7):1195-1199
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses
Arroyo Muhr LS; Eklund C; Lagheden C; Eriksson T; Pimenoff VN; Gray P; Lehtinen M; Dillner J
Article: BMJ OPEN. 2022;12(6):e056824
Association of Chlamydia trachomatis infection with cervical atypia in adolescent women with short-term or long-term use of oral contraceptives: a longitudinal study in HPV vaccinated women
Adhikari I; Eriksson T; Harjula K; Hokkanen M; Apter D; Nieminen P; Luostarinen T; Lehtinen M
Article: BMJ OPEN. 2021;11(12):e050669
Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Bly A; Gray P; Harjula K; Heikkila K; Hokkanen M; Karttunen H; Kuortti M; Nieminen P; Nummela M; Paavonen J; Palmroth J; Petaja T; Pukkala E; Soderlund-Strand A; Veivo U; Dillner J
Article: ENVIRONMENTAL EPIDEMIOLOGY. 2021;5(6):e182
Human exposome assessment platform
Martinez RM; Mueller H; Negru S; Ormenisan A; Muhr LSA; Zhang X; Moller FT; Clements MS; Kozlakidis Z; Pimenoff VN; Wilkowski B; Boeckhout M; Ohman H; Chong S; Holzinger A; Lehtinen M; van Veen E-B; Bala P; Widschwendter M; Dowling J; Tornroos J; Snyder MP; Dillner J
Article: CANCER MEDICINE. 2021;10(21):7759-7771
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
Lehtinen M; Apter D; Eriksson T; Harjula K; Hokkanen M; Natunen K; Nieminen P; Paavonen J; Palmroth J; Petaja T; Pukkala E; Vanska S; Cheuvart B; Soila M; Bi D; Struyf F
Article: THE LANCET INFECTIOUS DISEASES. 2021;21(10):1458-1468
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials
Mariz FC; Gray P; Render N; Eriksson T; Kann H; Apter D; Paavonen J; Pajunen E; Prager KM; Sehr P; Surcel H-M; Waterboer T; Mueller M; Pawlita M; Lehtinen M
Article: JOURNAL OF INFECTIOUS DISEASES. 2021;224(12 Suppl 2):S121-S127
Chlamydia trachomatis, Pelvic Inflammatory Disease, and Epithelial Ovarian Cancer
Paavonen J; Fortner RT; Lehtinen M; Idahl A
Article: JOURNAL OF INFECTIOUS DISEASES. 2021;224(3):481-491
Human Papillomavirus Genotype Replacement: Still Too Early to Tell?
Man I; Vanska S; Lehtinen M; Bogaards JA
Article: JOURNAL OF INFECTIOUS DISEASES. 2021;223(11):1992-2000
Sustained Cross-reactive Antibody Responses After Human Papillomavirus Vaccinations: Up to 12 Years Follow-up in the Finnish Maternity Cohort
Kann H; Lehtinen M; Eriksson T; Surcel H-M; Dillner J; Faust H
Article: PLOS MEDICINE. 2021;18(6):e1003588
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
Gray P; Kann H; Pimenoff VN; Eriksson T; Luostarinen T; Vanska S; Surcel H-M; Faust H; Dillner J; Lehtinen M
Article: PREVENTIVE MEDICINE. 2021;146:106473
Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial
Kalliala I; Eriksson T; Aro K; Hokkanen M; Lehtinen M; Gissler M; Nieminen P
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2021;190(4):506-514
Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
Vanska S; Luostarinen T; Lagheden C; Eklund C; Kleppe SN; Andrae B; Sparen P; Sundstrom K; Lehtinen M; Dillner J
Article: AMERICAN JOURNAL OF PREVENTIVE MEDICINE. 2021;60(4):478-487
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European Countries
Robles C; Bruni L; Acera A; Riera JC; Prats L; Poljak M; Mlakar J; Valencak AO; Eriksson T; Lehtinen M; Louvanto K; Hortlund M; Dillner J; Faber MT; Munk C; Kjaer SK; Petry KU; Denecke A; Xu L; Arbyn M; Cadman L; Cuzick J; Dalstein V; Clavel C; de Sanjose S; Bosch FX
Article: PREVENTIVE MEDICINE. 2021;144:106445
Elimination of HPV-associated oropharyngeal cancers in Nordic countries
Lehtinen T; Elfstrom KM; Makitie A; Nygard M; Vanska S; Pawlita M; Dillner J; Waterboer T; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(12):3511-3522
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomisedHPVvaccination trial with moderate coverage
Gray P; Kann H; Pimenoff VN; Adhikari I; Eriksson T; Surcel H-M; Vanska S; Dillner J; Faust H; Lehtinen M
Article: JOURNAL OF INFECTIOUS DISEASES. 2020;222(6):948-956
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
Vanska S; Luostarinen T; Baussano I; Apter D; Eriksson T; Natunen K; Nieminen P; Paavonen J; Pimenoff VN; Pukkala E; Soderlund-Strand A; Dubin G; Garnett G; Dillner J; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(2):440-447
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women
Louvanto K; Eriksson T; Gray P; Apter D; Baussano I; Bly A; Harjula K; Heikkila K; Hokkanen M; Huhtinen L; Ikonen M; Karttunen H; Nummela M; Soderlund-Strand A; Veivo U; Dillner J; Elfstom M; Nieminen P; Lehtinen M
Article: BRITISH JOURNAL OF CANCER. 2020;123(1):155-160
Impact of HPV vaccination on cervical screening performance: a population-based cohort study
Lei J; Ploner A; Lehtinen M; Sparen P; Dillner J; Elfstrom KM
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(1):170-174
Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trial
Lehtinen M; Apter D; Eriksson T; Harjula K; Hokkanen M; Lehtinen T; Natunen K; Damaso S; Soila M; Bi D; Struyf F
Article: NPJ VACCINES. 2020;5(1):14
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
Mariz FC; Bender N; Anantharaman D; Basu P; Bhatla N; Pillai MR; Prabhu PR; Sankaranarayanan R; Eriksson T; Pawlita M; Prager K; Sehr P; Waterboer T; Mueller M; Lehtinen M
Article: PATHOGENS. 2019;8(4):E276-276
The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland
Korhonen S; Hokynar K; Eriksson T; Natunen K; Paavonen J; Lehtinen M; Puolakkainen M
Article: GYNECOLOGIC ONCOLOGY. 2019;154(2):354-359
Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women
Aro K; Nieminen P; Louvanto K; Jakobsson M; Virtanen S; Lehtinen M; Dillner J; Kalliala I
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(3):785-796
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)
Gray P; Luostarinen T; Vanska S; Eriksson T; Lagheden C; Man I; Palmroth J; Pimenoff VN; Soderlund-Strand A; Dillner J; Lehtinen M
Article: MATHEMATICAL BIOSCIENCES. 2019;309:92-106
Fast approximate computation of cervical cancer screening outcomes by a deterministic multiple-type HPV progression model
Vanska S; Bogaards JA; Auranen K; Lehtinen M; Berkhof J
Article: JOURNAL OF INFECTIOUS DISEASES. 2019;219(4):582-589
Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity Cohort
Artemchuk H; Eriksson T; Poljak M; Surcel H-M; Dillner J; Lehtinen M; Faust H
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;143(9):2299-2310
Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)
Lehtinen M; Luostarinen T; Vanska S; Soderlund-Strand A; Eriksson T; Natunen K; Apter D; Baussano I; Harjula K; Hokkanen M; Kuortti M; Palmroth J; Petaja T; Pukkala E; Rekonen S; Siitari-Mattila M; Surcel H-M; Tuomivaara L; Paavonen J; Nieminen P; Dillner J; Dubin G; Garnett G
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(12):2491-2500
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)
Gray P; Palmroth J; Luostarinen T; Apter D; Dubin G; Garnett G; Eriksson T; Natunen K; Merikukka M; Pimenoff V; Soderlund-Strand A; Vanska S; Paavonen J; Pukkala E; Dillner J; Lehtinen M
Article: VACCINE. 2018;36(23):3239-3246
Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data
Vanska S; Soderlund-Strand A; Uhnoo I; Lehtinen M; Dillner J
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(5):949-958
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I)
Lehtinen M; Soderlund-Strand A; Vanska S; Luostarinen T; Eriksson T; Natunen K; Apter D; Baussano I; Harjula K; Hokkanen M; Kuortti M; Palmroth J; Petaja T; Pukkala E; Rekonen S; Siitari-Mattila M; Surcel H-M; Tuomivaara L; Paavonen J; Dillner J; Dubin G; Garnett G
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2018;23(1):12-17
The risk of cervical atypia in oral contraceptive users
Adhikari I; Eriksson T; Luostarinen T; Lehtinen M; Apter D
Article: CANCER MEDICINE. 2017;6(12):3060-3064
Cancer Registry follow-up for 17million person-years of a nationwide maternity cohort
Lehtinen M; Surcel H-M; Natunen K; Pukkala E; Dillner J
Article: JOURNAL OF INFECTIOUS DISEASES. 2017;216(8):966-968
Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 Vaccination
Lehtinen T; Soderlund-Strand A; Petaja T; Eriksson T; Jokiranta S; Natunen K; Dillner J; Lehtinen M
Article: BMJ OPEN. 2017;7(8):e015867
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petaja T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
Article: JOURNAL OF INFECTIOUS DISEASES. 2017;216(3):336-344
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study
Baussano I; Lazzarato F; Ronco G; Lehtinen M; Dillner J; Franceschi S
Article: CANCER RESEARCH. 2017;77(14):3951-3960
Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium
Ose J; Poole EM; Schock H; Lehtinen M; Arslan AA; Zeleniuch-Jacquotte A; Visvanathan K; Helzlsouer K; Buring JE; Lee I-M; Tjonneland A; Dossus L; Trichopoulou A; Masala G; Onland-Moret NC; Weiderpass E; Duell EJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Trabert B; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Article: CANCER CAUSES AND CONTROL. 2017;28(5):429-435
Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium
Ose J; Schock H; Poole EM; Lehtinen M; Visvanathan K; Helzlsouer K; Buring JE; Lee I-M; Tjonneland A; Boutron-Ruault M-C; Trichopoulou A; Mattiello A; Onland-Moret NC; Weiderpass E; Sanchez M-J; Idahl A; Travis RC; Rinaldi S; Merritt MA; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Article: CANCER RESEARCH. 2017;77(1):134-141
Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort
Fortner RT; Schock H; Kaaks R; Lehtinen M; Pukkala E; Lakso H-A; Tanner M; Kallio R; Joensuu H; Korpela J; Toriola AT; Hallmans G; Grankvist K; Zeleniuch-Jacquotte A; Toniolo P; Lundin E; Surcel H-M
Article: EMERGING INFECTIOUS DISEASES. 2016;22(10):1732-1740
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
Mesher D; Soldan K; Lehtinen M; Beddows S; Brisson M; Brotherton JML; Chow EPF; Cummings T; Drolet M; Fairley CK; Garland SM; Kahn JA; Kavanagh K; Markowitz L; Pollock KG; Soderlund-Strand A; Sonnenberg P; Tabrizi SN; Tanton C; Unger E; Thomas SL
Article: BMC PREGNANCY AND CHILDBIRTH. 2016;16(1):146
Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study
Schock H; Zeleniuch-Jacquotte A; Lundin E; Grankvist K; Lakso H-A; Idahl A; Lehtinen M; Surcel H-M; Fortner RT
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;138(9):2212-2220
Viremia during pregnancy and risk of childhood leukemia and lymphomas in the offspring: Nested case-control study
Bzhalava D; Hultin E; Muhr LSA; Ekstrom J; Lehtinen M; de Villiers E-M; Dillner J
Article: NATURE REVIEWS CLINICAL ONCOLOGY. 2016;13(2):119-132
HPV-FASTER: broadening the scope for prevention of HPV-related cancer
Xavier Bosch F; Robles C; Diaz M; Arbyn M; Baussano I; Clavel C; Ronco G; Dillner J; Lehtinen M; Petry K-U; Poljak M; Kjaer SK; Meijer CJLM; Garland SM; Salmeron J; Castellsague X; Bruni L; de Sanjose S; Cuzick J
Article: INTERNATIONAL JOURNAL OF CANCER. 2015;137(2):439-447
Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study
Schock H; Fortner RT; Surcel H-M; Grankvist K; Pukkala E; Lehtinen M; Lundin E
Article: CANCER RESEARCH. 2014;74(23):6958-6967
Early Pregnancy Sex Steroids and Maternal Breast Cancer: A Nested Case-Control Study
Fortner RT; Schock H; Kaaks R; Lehtinen M; Pukkala E; Lakso H-A; Tanner M; Kallio R; Joensuu H; Grankvist K; Zeleniuch-Jacquotte A; Toniolo P; Lundin E; Surcel H-M
Article: CANCER CAUSES AND CONTROL. 2014;25(5):583-589
Anti-Mullerian hormone and risk of invasive serous ovarian cancer
Schock H; Lundin E; Vaarasmaki M; Grankvist K; Fry A; Dorgan JF; Pukkala E; Lehtinen M; Surcel HM; Lukanova A
Article: ENDOCRINE-RELATED CANCER. 2014;21(6):831-844
Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer
Schock H; Surcel H-M; Zeleniuch-Jacquotte A; Grankvist K; Lakso H-A; Fortner RT; Kaaks R; Pukkala E; Lehtinen M; Toniolo P; Lundin E
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(7):1756-1759
Order of HPV/Chlamydia infections and cervical high-grade precancer risk: A case-cohort study
Luostarinen T; Namujju PB; Merikukka M; Dillner J; Hakulinen T; Koskela P; Paavonen J; Surcel H-M; Lehtinen M
Article: VIROLOGY. 2012;432(2):427-434
Phylogenetically diverse TT virus viremia among pregnant women
Bzhalava D; Ekstrom J; Lysholm F; Hultin E; Faust H; Persson B; Lehtinen M; de Villiers E-M; Dinner J
Article: JOURNAL OF MEDICAL ETHICS. 2012;38(4):247-249
Just implementation of human papillomavirus vaccination
Malmqvist E; Natunen K; Lehtinen M; Helgesson G
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;130(4):910-920
Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer
Lukanova A; Surcel H-M; Lundin E; Kaasila M; Lakso H-A; Schock H; Husing A; Kaaks R; Koskela P; Grankvist K; Pukkala E; Zeleniuch-Jacquotte A; Lehtinen M; Toniolo P
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2011;20(12):2541-2550
Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
Dahlstrom LA; Andersson K; Luostarinen T; Thoresen S; Ogmundsdottir H; Tryggvadottir L; Wiklund F; Skare GB; Eklund C; Sjolin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
Article: OBSTETRICS AND GYNECOLOGY. 2011;118(5):1029-1036
Determinants of Maternal Sex Steroids During the First Half of Pregnancy
Toriola AT; Vaarasmaki M; Lehtinen M; Zeleniuch-Jacquotte A; Lundin E; Rodgers K-G; Lakso H-A; Chen T; Schock H; Hallmans G; Pukkala E; Toniolo P; Grankvist K; Surcel H-M; Lukanova A
Article: CANCER CAUSES AND CONTROL. 2011;22(11):1607-1611
Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study
Toriola AT; Surcel H-M; Lundin E; Schock H; Grankvist K; Pukkala E; Chen T; Toniolo P; Lehtinen M; Zeleniuch-Jacquotte A; Lukanova A
Article: SEXUALLY TRANSMITTED INFECTIONS. 2011;87(5):372-376
Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
Lehtinen M; Ault KA; Lyytikainen E; Dillner J; Garland SM; Ferris DG; Koutsky LA; Sings HL; Lu S; Haupt RM; Paavonen J
Article: ANNALS OF ONCOLOGY. 2011;22(8):1916-1921
Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study
Toriola AT; Grankvist K; Agborsangaya CB; Lukanova A; Lehtinen M; Surcel H-M
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2011;20(8):1798-1801
Circulating Insulin-like Growth Factor-I in Pregnancy and Maternal Risk of Breast Cancer
Toriola AT; Lundin E; Schock H; Grankvist K; Pukkala E; Chen T; Zeleniuch-Jacquotte A; Toniolo P; Lehtinen M; Surcel H-M; Lukanova A
Article: CANCER CAUSES AND CONTROL. 2011;22(6):925-928
Association of serum 25-hydroxyvitamin D (25-OHD) concentrations with maternal sex steroids and IGF-1 hormones during pregnancy
Toriola AT; Surcel H-M; Husing A; Grankvist K; Lakso H-A; Schock H; Lundin E; Lehtinen M; Lukanova A
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2011;20(2):324-336
Circulating Sex Steroids during Pregnancy and Maternal Risk of Non-epithelial Ovarian Cancer
Chen T; Surcel H-M; Lundin E; Kaasila M; Lakso H-A; Schock H; Kaaks R; Koskela P; Grankvist K; Hallmans G; Pukkala E; Zeleniuch-Jacquotte A; Toniolo P; Lehtinen M; Lukanova A
Article: MEDICINE, HEALTH CARE AND PHILOSOPHY. 2011;14(1):19-27
The ethics of implementing human papillomavirus vaccination in developed countries
Malmqvist E; Helgesson G; Lehtinen J; Natunen K; Lehtinen M
Article: EUROPEAN JOURNAL OF CANCER. 2010;46(15):2799-2805
Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: A prospective nested case-control study
Toriola AT; Surcel H-M; Calypse A; Grankvist K; Luostarinen T; Lukanova A; Pukkala E; Lehtinen M
Article: CANCER RESEARCH. 2010;70(17):6779-6786
Human Chorionic Gonadotropin in Pregnancy and Maternal Risk of Breast Cancer
Toniolo P; Grankvist K; Wulff M; Chen T; Johansson R; Schock H; Lenner P; Hallmans G; Lehtinen M; Kaaks R; Wadell G; Zeleniuch-Jacquotte A; Lundin E; Lukanova A
Article: THE BMJ. 2010;341:c3493
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen O-E; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson S-E; Tang GWK; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Munoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2010;42(6-7):522-526
Risk of being seropositive for multiple human papillomavirus types among Finnish and Ugandan women
Namujju PB; Surcel H-M; Kirnbauer R; Kaasila M; Banura C; Byaruhanga R; Muwanga M; Mbidde EK; Koskela P; Lehtinen M
Article: EUROPEAN JOURNAL OF CANCER. 2010;46(2):364-369
Serum 25-hydroxyvitamin D and the risk of ovarian cancer
Toriola AT; Surcel H-M; Agborsangaya C; Grankvist K; Tuohimaa P; Toniolo P; Lukanova A; Pukkala E; Lehtinen M
Article: NUTRITION AND CANCER. 2009;62(1):51-57
The Effects of Storage Time and Sampling Season on the Stability of Serum 25-Hydroxy Vitamin D and Androstenedione
Agborsangaya C; Toriola AT; Grankvist K; Surcel H-M; Holl K; Parkkila S; Tuohimaa P; Lukanova A; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(8):1851-1858
Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-A candidate gene approach
Castro FA; Haimila K; Sareneva I; Schmitt M; Lorenzo J; Kunkel N; Kumar R; Forsti A; Kjellberg L; Hallmans G; Lehtinen M; Hemminki K; Pawlita M
Article: CANCER PREVENTION RESEARCH. 2009;2(10):868-878
A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
Kjaer SK; Sigurdsson K; Iversen O-E; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson S-E; Tang GWK; Ferris DG; Paavonen J; Lehtinen M; Steben M; Xavier Bosch F; Dillner J; Joura EA; Majewski S; Munoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Lu S; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM
Article: HUMAN VACCINES. 2009;5(10):696-704
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection
Olsson S-E; Kjaer SK; Sigurdsson K; Iversen O-E; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Tang GWK; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Dillner J; Joura EA; Majewski S; Munoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Maansson R; Vuocolo S; Hesley TM; Saah A; Barr E; Haupt RM
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2009;18(10):2790-2792
No Risk of Maternal EBV Infection for Childhood Leukemia
Tedeschi R; Luostarinen T; Marus A; Bzhalava D; Ogmundsdottir HM; Dillner J; De Paoli P; Surcel H-M; Pukkala E; Lehtinen M; Lehtinen T
Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(12):2923-2928
Endogenous steroid hormone levels in early pregnancy and risk of testicular cancer in the offspring: A nested case-referent study
Holl K; Lundin E; Surcel H-M; Grankvist K; Koskela P; Dillner J; Hallmans G; Wadell G; Olafsdottir GH; Ogmundsdottir HM; Pukkala E; Lehtinen M; Stattin P; Lukanova A
Article: EUROPEAN JOURNAL OF CANCER. 2009;45(9):1640-1648
Maternal smoking during pregnancy and testicular cancer in the sons: A nested case-control study and a meta-analysis
Tuomisto J; Holl K; Rantakokko P; Koskela P; Hallmans G; Wadell G; Stattin P; Dillner J; Ogmundsdottir HM; Vartiainen T; Lehtinen M; Pukkala E
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2009;169(4):480-488
Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks
Kapeu AS; Luostarinen T; Jellum E; Dillner J; Hakama M; Koskela P; Lenner P; Love A; Mahlamaki E; Thoresen S; Tryggvadottir L; Wadell G; Youngman L; Lehtinen M
Article: VACCINE. 2008;26(52):6844-6851
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversene O-E; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olssonn S-E; Tang GWK; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurmanv RJ; Majewski S; Munoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinaccia LC; Giacoletti KED; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E
Article: APMIS. 2008;116(9):816-822
Maternal Epstein-Barr virus and cytomegalovirus infections and risk of testicular cancer in the offspring:: a nested case-control study
Holl K; Surcel H-M; Koskela P; Dillner J; Hallmans G; Wadell G; Kaasila M; Olafsdottir GH; Ogmundsdottir HM; Pukkala E; Stattin P; Lehtinen M
Article: ACTA ONCOLOGICA. 2008;47(3):406-412
Effect of long-term storage on hormone measurements in samples from pregnant women: The experience of the Finnish Maternity Cohort
Holl K; Lundin E; Kaasila M; Grankvist K; Afanasyeva Y; Hallmans G; Lehtinen M; Pukkala E; Surcel H-M; Toniolo P; Zeleniuch-Jacquotte A; Koskela P; Lukanova A
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2008;40(9):745-751
Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
Simen-Kapeu A; Kataja V; Yliskoski M; Syrjanen K; Dillner J; Koskela P; Paavonen J; Lehtinen M
Article: JOURNAL OF INFECTIOUS DISEASES. 2007;196(10):1438-1446
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
Villa LL; Perez G; Kjaer SK; Paavonen J; Lehtinen M; Munoz N; Sigurdsson K; Hernandez-Avila M; Iversen OE; Thoresen S; Garcia PJ; Majewski S; Tay EH; Bosch FX; Dillner J; Olsson S-E; Ault KA; Brown DR; Ferris DG; Koutsky LA; Kurman RJ; Myers ER; Barr E; Boslego J; Bryan J; Esser MT; Hesley TM; Nelson M; Railkar R; James M; Sattler C; Taddeo FJ; Thornton AR; Vuocolo SC
Article: JOURNAL OF VIROLOGY. 2007;81(17):9346-9356
In vivo and in vitro intragenomic rearrangement of TT viruses
Leppik L; Gunst K; Lehtinen M; Dillner J; Streker K; de Villiers E-M
Article: VACCINE. 2007;25(26):4931-4939
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Olsson S-E; Villa LL; Costa RLR; Petta CA; Andrade RP; Malm C; Iversen O-E; Hoye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
Article: THE LANCET. 2007;369(9576):1861-1868
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ:: a combined analysis of four randomised clinical trials
Villa L; Perez G; Kjaer S; Lehtinen M; Paavonen J; Munoz N; Sigurdsson K; Hernandez-Avila M; Iversen OE; Thoresen S; Garcia P; Majewski S; Tay EH; Bosch FX; Dillner J; Olsson SE; Ault K; Brown D; Ferris D; Giuliano A; Koutsky L; Kurman R; Myers E; Barr E; Boslego J; Bryan J; Esser M; Hesley T; Lupinacci L; Railkar R; Sings H; Taddeo F; Thornton A
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2007;356(19):1915-1927
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Villa LL; Perez G; Kjaer SK; Paavonen J; Lehtinen M; Munoz N; Sigurdsson K; Hernandez-Avila M; Skjeldestad FE; Thoresen S; Garcia P; Majewski S; Dillner J; Olsson S-E; Tay EH; Bosch FX; Ault KA; Brown DR; Ferris DG; Koutsky LA; Kurman RJ; Myers ER; Barr E; Boslego J; Bryan J; Esser MT; Gause CK; Hesley TM; Lupinacci LC; Sings HL; Taddeo FJ; Thornton AR; Boulos M; Cox JT; Langmark F; Modlin J; Munoz A; Odlind V; Wilkinson E; Ferenczy A; Kurman R; Ronett B; Stoler M; Andreoni G; Bahamondes L; Camargos A; Costa R; De Andrade R; Fedrizzi E; Ferriani R; Goncalves M; Laginha F; Mendonca J; Moreira EJ; Nonnenmacher B; Taborda W; Zanetta D; Ardila J; Balcazar N; Maldonado I; Revollo F; Ruiz A; Andersen ES; Djursing H; Hansen T; Jorgensen JJ; Nilas L; Ottesen B; Petersen LK; Thomsen SG; Toftager-Larsen K; Apter D; Kekki M; Kuortti M; Lahti L; Lindroos Y; Lunnas T; Paavonen J; Palmroth J; Sigurdsson K; Lazcano E; Zertuche J; Dalaker K; Eriksen B; Erno LE; Fiane B; Hesla K; Isachsen MM; Iversen OE; Kasin K; Kristoffersen M; Lunde T; Nordmark PT; Nygaard T; Onsrud M; Riis-Johannessen G; Schiotz H; Skjeldestad FE; Sundhagen H; Sviggum O; Trosterud KA; Garcia P; Penny M; Vivar A; Basta A; Czajkowski K; Knapp P; Spaczynski M; Barnes R; Tay EH; Elfgren K; Hardmeier E; Hellsten C; Hofte C; Jensen P; Johannisson G; Loewhagen G-B; Olsson S-E; Steinwall M; Tamsen L; Varnauskas T; Wikstroem A; Crawford G; Allen B; Ault K; Brown D; Edwards R; Comerci J; Giuliano A; Greer S; Hatch K; Kriesel J; Lalezari J; Partridge E; Sperling R; Spruance S; Stapleton J; Wright P; Zedler P; McCarroll K; Zhang L; Zhou H
Article: BRITISH JOURNAL OF CANCER. 2007;96(3):514-518
Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
French KM; Barnabas RV; Lehtinen M; Kontula O; Pukkala E; Dillner J; Garnett GP
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2007;165(2):134-137
Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring
Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
Article: ACTA ONCOLOGICA. 2007;46(3):286-307
Nordic biological specimen banks as basis for studies of cancer causes and control -: more than 2 million sample donors, 25 million person years and 100 000 prospective cancers
Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyronen PP; Lenner P; Luostarinen T; Love A; Ogmundsdottir H; Stattin P; Tenkanen L; Tryggvadottir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
Article: BRITISH JOURNAL OF CANCER. 2006;95(11):1459-1466
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
Villa LL; Costa RLR; Petta CA; Andrade RP; Paavonen J; Iversen O-E; Olsson S-E; Hoye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Malm C; Tamms GM; Giacoletti K; Lupinacci L; Railkar R; Taddeo FJ; Bryan J; Esser MT; Sings HL; Saah AJ; Barr E
Article: VACCINE. 2006;24:S3/233-S3/241
Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
Lehtinen M; Herrero R; Mayaud P; Barnabas R; Dillner J; Paavonen J; Smith PG
Article: VACCINE. 2006;24(27-28):5571-5583
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Villa LL; Ault KA; Giuliano AR; Costa RLR; Petta CA; Andrade RP; Brown DR; Ferenczy A; Harper DM; Koutsky LA; Kurman RJ; Lehtinen M; Malm C; Olsson S-E; Ronnett BM; Skjeldestad FE; Steinwall M; Stoler MH; Wheeler CM; Taddeo FJ; Yu J; Lupinacci L; Railkar R; Marchese R; Esser MT; Bryan J; Jansen KU; Sings HL; Tamms GM; Saah AJ; Barr E
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2005;14(12):2952-2955
Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: A Nordic nested case-control study
Korodi Z; Dillner J; Jellum E; Lumme S; Hallmans G; Thoresen S; Hakulinen T; Stattin P; Luostarinen T; Lehtinen M; Hakama M
Article: BRITISH JOURNAL OF CANCER. 2005;93(7):834-837
Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
Tedeschi R; Luostarinen T; De Paoli P; Gislefoss RE; Tenkanen L; Virtamo J; Koskela P; Hallmans G; Lehtinen M; Dillner J
Article: JOURNAL OF GENERAL VIROLOGY. 2005;86(Pt 6):1703-1708
Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles
Lundstig A; Eliasson L; Lehtinen M; Sasnauskas K; Koskela P; Dillner J
Article: THE LANCET ONCOLOGY. 2005;6(5):271-278
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Villa LL; Costa RLR; Petta CA; Andrade RP; Ault KA; Giuliano AR; Wheeler CM; Koutsky LA; Malm C; Lehtinen M; Skjeldestad FE; Olsson SE; Steinwall M; Brown DR; Kurman R; Ronnett BM; Stoler MH; Ferenczy A; Harper DM; Tamms GM; Yu J; Lupinacci L; Railkar R; Taddeo FJ; Jansen KU; Esser MT; Sings HL; Saah AJ; Lupinacci L
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2005;14(2):385-389
Chlamydial antibodies and risk of prostate cancer
Anttila T; Tenkanen L; Lumme S; Leinonen M; Gislefoss RE; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Stattin P; Saikku P; Dillner J; Lehtinen M; Anttila T; Tenkanen L; Lumme S; Leinonen M; Gislefoss RE; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Stattin P; Saikku P; Dillner J; Lehtinen M; Hakama M
Article: INTERNATIONAL JOURNAL OF CANCER. 2005;113(3):393-396
Maternal human polyomavirus infection and risk of neuroblastoma in the child
Stolt A; Kjellin M; Sasnauskas K; Luostarinen T; Koskela P; Lehtinen M; Dillner J
Article: EUROPEAN JOURNAL OF CANCER. 2004;40(7):1058-1065
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri
Luostarinen T; Lehtinen M; Bjorge T; Abeler V; Hakama M; Hallmans G; Jellum E; Koskela P; Lenner P; Lie AK; Paavonen J; Pukkala E; Saikku P; Sigstad E; Thoresen S; Youngman LD; Dillner J; Hakulinen T
Article: INTERNATIONAL JOURNAL OF CANCER. 2004;108(3):418-424
High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective study
Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
Article: INTERNATIONAL JOURNAL OF CANCER. 2004;108(1):104-108
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries
Tuohimaa P; Tenkanen L; Ahonen M; Lumme S; Jellum E; Hallmans G; Stattin P; Harvei S; Hakulinen T; Luostarinen T; Dillner J; Lehtinen M; Hakama M
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003;189(5):1287-1292
Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer
Paavonen J; Karunakaran KP; Noguchi Y; Anttila T; Bloigu A; Diller J; Hallmans G; Hakulinen T; Jellum E; Koskela P; Lehtinen M; Thoresen S; Lam H; Shen C; Brunham RC
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2003;158(3):207-213
Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring
Lehtinen M; Koskela P; Ögmundsdottir HM; Bloigu A; Dillner J; Gudnadottir M; Hakulinen T; Kjartansdottir A; Kvarnung M; Pukkala E; Tulinius H; Lehtinen T
Article: JOURNAL OF GENERAL VIROLOGY. 2003;84(Pt 8):2105-2109
Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland
Laukkanen P; Koskela P; Pukkala E; Dillner J; Läära E; Knekt P; Lehtinen M
Article: JOURNAL OF GENERAL VIROLOGY. 2003;84(Pt 6):1499-1504
Seroepidemiology of the human polyomaviruses
Stolt A; Sasnauskas K; Koskela P; Lehtinen M; Dillner J
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003;188(1):49-55
Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later
Lehtinen M; Pawlita M; Zumbach K; Lie K; Hakama M; Jellum E; Koskela P; Luostarinen T; Paavonen J; Pukkala E; Sigstad E; Thoresen S; Dillner J
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2002;156(8):687-692
Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the Nordic countries
Lehtinen M; Koskela P; Jellum E; Bloigu A; Anttila T; Hallmans G; Luukkaala T; Thoresen S; Youngman L; Dillner J; Hakama M
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;101(4):371-374
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma
Wallin KL; Wiklund F; Luostarinen T; Ångström T; Anttila T; Bergman F; Hallmans G; Ikäheimo I; Koskela P; Lehtinen M; Stendahl U; Paavonen J; Dillner J
Article: BRITISH JOURNAL OF CANCER. 2002;87(2):175-180
A prospective study of the relationship between prediagnostic Human Papillomavrus seropositivity and HPV DNA in subsequent cervical carcinomas
Sigstad E; Lie AK; Luostarinen T; Dillner J; Jellum E; Lehtinen M; Thoresen S; Abeler V
Article: BRITISH JOURNAL OF CANCER. 2002;87(1):61-64
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
Bjorge T; Engeland A; Luostarinen T; Mork J; Gislefoss RE; Jellum E; Koskela P; Lehtinen M; Pukkala E; Thoresen SO; Dillner J
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;99(1):124-129
Circulating enterolactone and prostate cancer risk: A Nordic nested case-control
Stattin P; Adlercreutz H; Tenkanen L; Jellum E; Lumme S; Hallmans G; Harvei S; Teppo L; Stumpf K; Luostarinen T; Lehtinen M; Dillner J; Hakama M
Article: JOURNAL OF CLINICAL VIROLOGY. 2001;22(1):117-124
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
Lehtinen M; Luukkaala T; Wallin KL; Paavonen J; Thoresen S; Dillner J; Hakama M
Article: JOURNAL OF MEDICAL MICROBIOLOGY. 2001;50(5):468-471
Poor antibody response against human papillomavirus in adult-onset laryngeal papillomatosis
Aaltonen LM; Auvinen E; Dillner J; Lehtinen M; Paavonen J; Rihkanen H; Vaheri A
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2001;344(15):1125-1131
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
Mork J; Lie AK; Glattre E; Clark S; Hallmans G; Jellum E; Koskela P; Moller B; Pukkala E; Schiller JT; Youngman L; Lehtinen M; Dillner J
Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2001;285(1):47-51
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
Anttila T; Saikku P; Koskela P; Bloigu A; Dillner J; Ikäheimo I; Jellum E; Lehtinen M; Lenner P; Hakulinen T; Närvänen A; Pukkala E; Thoresen S; Youngman L; Paavonen J
Article: CANCER CAUSES AND CONTROL. 2000;11(9):783-790
Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer:: antagonism or misclassification (Nordic countries)
Hakama M; Luostarinen T; Hallmans G; Jellum E; Koskela P; Lehtinen M; Thoresen S; Youngman L; Hakulinen T
Article: SEXUALLY TRANSMITTED DISEASES. 2000;27(8):425-430
Seropositivity to multiple sexually transmitted infections is not common
Kibur M; Koskela P; Dillner J; Leinikki P; Saikku P; Lehtinen M; Hakama M
Article: SEXUALLY TRANSMITTED INFECTIONS. 2000;76(1):13-17
Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination
Kibur M; af Geijerstamm V; Pukkala E; Koskela P; Luostarinen T; Paavonen J; Schiller J; Wang Z; Dillner J; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2000;85(1):35-39
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
Koskela P; Anttila T; Bjorge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
Article: INTERNATIONAL JOURNAL OF CANCER. 1999;80(6):818-822
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11
Luostarinen T; af Geijersstam V; Bjorge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Article: NUTRITION AND CANCER. 1999;34(2):229-234
Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: Interaction with HPV seropositivity
Lehtinen M; Luostarinen T; Youngman LD; Anttila T; Dillner J; Hakulinen T; Koskela P; Lenner P; Hallmans G
Article: INTERNATIONAL JOURNAL OF CANCER. 1998;75(4):564-567
Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer
Dillner J; Knekt P; Boman J; Lehtinen M; Af Geijersstam V; Sapp M; Schiller J; Maatela J; Aromaa A
Article: CANCER RESEARCH. 1997;57(18):3989-3992
A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway
Bjorge T; Hakulinen T; Engeland A; Jellum E; Koskela P; Lehtinen M; Luostarinen T; Paavonen J; Sapp M; Schiller J; Thoresen S; Wang ZH; Youngman L; Dillner J
Article: THE BMJ. 1997;315(7109):646-649
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers
Bjorge T; Dillner J; Anttila T; Engeland A; Hakulinen T; Jellum E; Lehtinen M; Luostarinen T; Paavonen J; Pukkala E; Sapp M; Schiller J; Youngman L; Thoresen S
Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 1997;89(17):1293-1299
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
Dillner J; Lehtinen M; Bjorge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
Article: JOURNAL OF INFECTIOUS DISEASES. 1996;173(6):1394-1398
Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior
Dillner J; Kallings I; Brihmer C; Sikstrom P; Koskela P; Lehtinen M; Schiller JT; Sapp M; Mardh PA
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;93(1):104-110
Serum p53 accumulation and altered antibody responses to Epstein-Barr virus proteins precede diagnosis of haemopoietic malignancies of lymphoid origin
Lehtinen T; Luostarinen T; Dillner J; Aromaa A; Hakama M; Hakulinen T; Knekt P; Leinikki P; Lumio J; Lahdeaho ML; Maatela J; Teppo L; Lehtinen M
Article: THE BMJ. 1996;312(7030):537-539
Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: Nested case-control study
Lehtinen M; Dillner J; Knekt P; Luostarinen T; Aromaa A; Kimbauer R; Koskela P; Paavonen J; Peto R; Schiller JT; Hakama M
Article: JOURNAL OF GENERAL VIROLOGY. 1995;76:1141-1153
HUMAN PAPILLOMAVIRUS TYPE-16 CAPSIDS EXPOSE MULTIPLE TYPE-RESTRICTED AND TYPE-COMMON ANTIGENIC EPITOPES
HEINO P; SKYLDBERG B; LEHTINEN M; RANTALA I; HAGMAR B; KREIDER JW; KIRNBAUER R; DILLNER J
Visa fler

Alla övriga publikationer

Review: INTERNATIONAL JOURNAL OF CANCER. 2023;152(6):1060-1068
Assessing the risk of cervical neoplasia in the post-HPV vaccination era
Lehtinen M; Pimenoff VN; Nedjai B; Louvanto K; Verhoef L; Heideman DAM; El-Zein M; Widschwendter M; Dillner J
Editorial comment: GASTROENTEROLOGY. 2022;163(1):305-307.e4
Association of Helicobacter pylori and Autoimmune Gastritis With Stomach Cancer in a Cohort of Young Finnish Women
Butt J; Lehtinen M; Ohman H; Waterboer T; Epplein M
Editorial comment: EXPERT REVIEW OF VACCINES. 2022;21(6):735-738
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers
Lehtinen M; Gray P; Louvanto K; Vanska S
Editorial comment: EUROSURVEILLANCE. 2021;26(50):2101154
Moral dilemma(s) in human papillomavirus vaccination - revisiting the role of the herd effect
Lehtinen M; Pimenoff VN
Review: EXPERT REVIEW OF VACCINES. 2019;18(2):153-160
Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies
Lehtinen M; Baussano I; Paavonen J; Vanska S; Dillner J
Editorial comment: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2018;97(9):1049-1050
Which human papillomavirus vaccine and vaccination strategy for national programs?
Lehtinen M
Letter: INTERNATIONAL JOURNAL OF CANCER. 2018;142(10):2186-2187
Vaccination protects against invasive HPV-associated cancers
Luostarinen T; Apter D; Dillner J; Eriksson T; Harjula K; Natunen K; Paavonen J; Pukkala E; Lehtinen M
Letter: THE LANCET ONCOLOGY. 2015;16(9):e422-e423
Fewer than three doses of HPV vaccine
Lehtinen M; Dillner J
Review: NATURE REVIEWS CLINICAL ONCOLOGY. 2013;10(7):400-410
Clinical trials of human papillomavirus vaccines and beyond
Lehtinen M; Dillner J
Corrigendum: OBSTETRICS AND GYNECOLOGY. 2012;119(1):186-187
Determinants of Maternal Sex Steroids During the First Half of Pregnancy (vol 118, pg 1029, 2011)
Toriola AT; Vaarasmaki M; Lehtinen M; Zeleniuch-Jacquotte A; Lundin E; Rodgers K-G; Lakso H-A; Chen T; Schock H; Hallmans G; Pukkala E; Toniolo P; Grankvist K; Surcel H-M; Lukanova A
Review: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2008;87(5):489-498
Strengthening prevention programs to eliminate cervical cancer in the Nordic countries
Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
Letter: INTERNATIONAL JOURNAL OF CANCER. 2004;111(3):469
Metabolism of 25-hydroxyvitamin D₃ may explain the U-shaped risk curve for prostate cancer
Tuohimaa P; Tenkanen L; Ahonen M; Lumme S; Jellum E; Hallmans G; Stattin P; Harvei S; Hakulinen T; Luostarinen T; Dillner J; Lehtinen M; Hakama M
Editorial comment: SEXUALLY TRANSMITTED INFECTIONS. 2002;78(1):4-6
Preventive human papillomavirus vaccination
Lehtinen M; Dillner J
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2001;345(5):377
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck - Reply
Mork J; Lehtinen M; Dillner J
Published conference paper: JOURNAL OF CLINICAL VIROLOGY. 2000;19(1-2):25-30
Prerequisites for human papillomavirus vaccine trial: results of feasibility studies
Paavonen J; Halttunen M; Hansson BG; Nieminen P; Rostila T; Lehtinen M
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 2000;181(2):456-462
Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids
Wang ZH; Kjellberg L; Abdalla H; Wiklund F; Eklund C; Knekt P; Lehtinen M; Kallings I; Lenner P; Hallmans G; Mählck CG; Wadell G; Schiller J; Dillner J
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 1998;177(6):1710-1714
Stability over time of serum antibody levels to human papillomavirus type 16
af Geijersstam V; Kibur M; Wang ZH; Koskela P; Pukkala E; Schiller J; Lehtinen M; Dillner J

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI